Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer
Authors:
- 21 March 2023
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 41 (5) , 256.e9-256.e15
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Active surveillance for low-risk bladder cancerUrologic Oncology: Seminars and Original Investigations, 2014
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011
- Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder TumorsUrology, 2009
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Clinical model of lifetime cost of treating bladder cancer and associated complicationsUrology, 2006
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Watchful Waiting Policy in Recurrent Ta G1 Bladder TumorsEuropean Urology, 2006
- A SURVEILLANCE SCHEDULE FOR G1Ta BLADDER CANCER ALLOWING EFFICIENT USE OF CHECK CYSTOSCOPY AND SAFE DISCHARGE AT 5 YEARS BASED ON A 25-YEAR PROSPECTIVE DATABASEJournal of Urology, 2005
- The health economics of bladder cancerPharmacoEconomics, 2003
- Efficient Scheduling of Cystoscopies in Monitoring for Recurrent Bladder CancerMedical Decision Making, 1989